Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
-
25/04/2025, 07:04
-
ansa.it
0
Scopri altro
- 25/06/2025, 07:04
-
ansa.it
-
0
- 25/06/2025, 06:04
-
ansa.it
-
0
- 25/06/2025, 05:55
-
repubblica.it
-
0
- 25/06/2025, 04:03
-
ansa.it
-
0
- 25/06/2025, 03:43
-
ansa.it
-
0
- 25/06/2025, 01:48
-
ansa.it
-
0
- 24/06/2025, 23:52
-
ansa.it
-
0
Nessun commento